ORIGINAL RESEARCH
Published on 19 Sep 2024
Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis
doi 10.3389/fonc.2024.1441254
- 517 views